Report: Biotech Uncertainty, Instability Bogged Down 2025
Massachusetts-headquartered biopharma companies secured $6.85 billion in venture capital funding last year – the smallest haul since 2019.
State Should Target Western Mass. for Biomanufacturing Push
Massachusetts can be a winner in the federal government’s push to bring biomanufacturing back to the United States – if it plays its cards right.
Beacon Hill Must Keep Biotech’s Flywheel Turning
To maintain Massachusetts’ leadership in global drug development, we cannot allow uncertainty and alarm bells coming from its biotech sector to paralyze us.
Don’t Bet on Filling Those Lab Buildings Any Time Soon
The Bay State’s life sciences sector now faces the prospect of a potential retrenchment amid slashing cuts to research funding and drops in venture capital funding.
Boston’s Lab Market Faced Glut of Space. Now It’s Got a Shrinking Tenant Pool, Too
An annual state-of-the-industry report by Massachusetts’ main biotech trade group is full of unwelcome news to developers, investors and lenders exposed to the state’s life science real estate market.
Report: Life Sciences Job Growth Slowed Way Down in 2024
Total employment in the Massachusetts life sciences industry remained effectively flat in 2024, a key source of pressure for lab landlords.
Healey Warns Researchers Leaving Mass., Students May Stay Away
Massachusetts’ top politician says Trump administration research cuts and attempts to deport foreign students over their political views could deal serious blows to two of the state’s biggest industries.
MassBio Maps Rescue Plan for Life Science Startups
The free-flowing funding climate in biotech slowed to a trickle in 2022, choking off the supply of tenants to fill Boston’s explosion of new life science real estate.
Massachusetts Shoots for Leadership in the ‘Hard Stuff’
Massachusetts lost biomanufacturing jobs last year, raising questions about the sector’s future in the state. But local and state leaders are planning initiatives to show the Bay State remains a formidable powerhouse.
Laying the Groundwork for a Biotech Rebound
Despite the spring’s bad headlines, this summer ended with a pile of venture capital deals and two more Bay State biotech IPOs. It’s time for Beacon Hill to do its part to keep that momentum going.
Biomanufacturing Lost Traction in Mass.
Massachusetts’ life science industry added R&D jobs but lost traction in biomanufacturing, a hoped-for source of new jobs and economic growth outside of the Greater Boston cluster.
Everyone Wants a Piece of Biotech Startups
As life science tenant space requirements become scarcer in the more conservative venture capital climate, Boston area developers are adapting to the new leasing landscape with incubator space aimed at small startups.
Life Science Expansion Favors New Markets
Massachusetts life science industry is expanding into new submarkets and creating fast-growing job clusters from Boston to Worcester despite a more challenging funding climate.
Biotech Group Predicts 42K New Jobs by 2032
The state’s biggest biotech landlords may be hitting pause on new developments or, in some cases, abandoning projects entirely. But those headlines haven’t dampened enthusiastic predictions from the life science industry’s leading trade group.
VC Funding for Bay State Biotechs Dropped 36 Percent
A major source of funding for Massachusetts life science companies dropped sharply in 2022, but still exceeds pre-pandemic investment levels.
Leading Life Science Clusters Share Strengths and Risks
Neither Boston nor San Francisco are likely to cede their top spots in the life science ecosystem to challengers with lower costs and more affordable development sites, even as the sector enters a contraction phase.
Biotech Expands Beyond Cambridge Comfort Zone
Planned life science developments are expanding into Massachusetts’ Gateway Cities, providing a new source of jobs and tax revenues and positioning the industry for a healthier future that benefits more Bay Staters.
In Andover, a Welcome Mat for Biotech Growth
Andover already has about 2 million square feet of building space devoted to life sciences, and is looking to add even more.
Biogen Seeks to Sublease Cambridge, Weston Properties
Biogen is offering over 263,000 square feet of office and research space in Cambridge and Weston for sublease in the latest retrenchment of the life science industry’s local footprint.
Lobby Art Raises Funds for Research
When Boston Private wanted to present board members and clients with artwork several years ago, they turned to Art in Giving, co-founded by Eliane Markoff. The nonprofit raises money for pediatric cancer research.
